Loading clinical trials...
Loading clinical trials...
A Proof of Concept (PoC) Study to Evaluate the Safety, Tolerability, and Efficacy of 12 Week Administration of BFH772 Ointment in Rosacea Patients
Conditions
Interventions
BFH772 1% ointment
Vehicle ointment
+1 more
Locations
6
United States
Novartis Investigative Site
Hot Springs, Arkansas, United States
Novartis Investigative Site
Ann Arbor, Michigan, United States
Novartis Investigative Site
Paramus, New Jersey, United States
Novartis Investigative Site
Portland, Oregon, United States
Novartis Investigative Site
Austin, Texas, United States
Novartis Investigative Site
Spokane, Washington, United States
Start Date
September 1, 2011
Primary Completion Date
February 1, 2012
Completion Date
February 1, 2012
Last Updated
February 21, 2021
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions